The function of Golgi apparatus in LRRK2-associated Parkinson's disease

被引:4
|
作者
Wei, Yonghang [1 ]
Awan, Maher un Nisa [1 ]
Bai, Liping [1 ]
Bai, Jie [1 ]
机构
[1] Kunming Univ Sci & Technol, Med Sch, Lab Mol Neurobiol, Kunming, Peoples R China
来源
FRONTIERS IN MOLECULAR NEUROSCIENCE | 2023年 / 16卷
基金
中国国家自然科学基金;
关键词
Parkinson's; LRRK2; Rab29; VPS52; PKC; Golgi apparatus; ANIMAL-MODELS; LRRK2; KINASE; FRAGMENTATION; PROTEINS; PHOSPHORYLATION; TRAFFICKING; RAB; MUTATIONS; TRANSPORT;
D O I
10.3389/fnmol.2023.1097633
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a chronic neurodegenerative disease associated with the intracellular organelles. Leucine-rich repeat kinase 2 (LRRK2) is a large multi-structural domain protein, and mutation in LRRK2 is associated with PD. LRRK2 regulates intracellular vesicle transport and function of organelles, including Golgi and lysosome. LRRK2 phosphorylates a group of Rab GTPases, including Rab29, Rab8, and Rab10. Rab29 acts in a common pathway with LRRK2. Rab29 has been shown to recruit LRRK2 to the Golgi complex (GC) to stimulate LRRK2 activity and alter the Golgi apparatus (GA). Interaction between LRRK2 and Vacuolar protein sorting protein 52 (VPS52), a subunit of the Golgi-associated retrograde protein (GARP) complex, mediates the function of intracellular soma trans-Golgi network (TGN) transport. VPS52 also interacts with Rab29. Knockdown of VPS52 leads to the loss of LRRK2/Rab29 transported to the TGN. Rab29, LRRK2, and VPS52 work together to regulate functions of the GA, which is associated with PD. We highlight recent advances in the roles of LRRK2, Rabs, VPS52, and other molecules, such as Cyclin-dependent kinase 5 (CDK5) and protein kinase C (PKC) in the GA, and discuss their possible association with the pathological mechanisms of PD.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] LRRK2, lysosome damage, and Parkinson's disease
    Bentley-DeSousa, Amanda
    Clegg, Devin
    Ferguson, Shawn M.
    CURRENT OPINION IN CELL BIOLOGY, 2025, 93
  • [32] Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease
    Blauwendraat, Cornelis
    Reed, Xylena
    Kia, Demis A.
    Gan-Or, Ziv
    Lesage, Suzanne
    Pihistrom, Lasse
    Guerreiro, Rita
    Gibbs, J. Raphael
    Sabir, Marya
    Ahmed, Sarah
    Ding, Jinhui
    Alcalay, Roy N.
    Hassin-Baer, Sharon
    Pittman, Alan M.
    Brooks, Janet
    Edsall, Connor
    Hernandez, Dena G.
    Chung, Sun Ju
    Goldwurm, Stefano
    Toft, Mathias
    Schulte, Claudia
    Bras, Jose
    Wood, Nicholas W.
    Brice, Alexis
    Morris, Huw R.
    Scholz, Sonja W.
    Nalls, Mike A.
    Singleton, Andrew B.
    Cookson, Mark R.
    JAMA NEUROLOGY, 2018, 75 (11) : 1416 - 1422
  • [33] Golgi Apparatus and Protein Trafficking in Alzheimer's Disease
    Baloyannis, Stavros J.
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 : S153 - S162
  • [34] Lrrk2 pathogenic substitutions in Parkinson's disease
    Mata, IF
    Kachergus, JM
    Taylor, JP
    Lincoln, S
    Aasly, J
    Lynch, T
    Hulihan, MM
    Cobb, SA
    Wu, RM
    Lu, CS
    Lahoz, C
    Wszolek, ZK
    Farrer, MJ
    NEUROGENETICS, 2005, 6 (04) : 171 - 177
  • [35] Lrrk2 pathogenic substitutions in Parkinson's disease
    Ignacio F. Mata
    Jennifer M. Kachergus
    Julie P. Taylor
    Sarah Lincoln
    Jan Aasly
    Timothy Lynch
    Mary M. Hulihan
    Stephanie A. Cobb
    Ruey-Meei Wu
    Chin-Song Lu
    Carlos Lahoz
    Zbigniew K. Wszolek
    Matthew J. Farrer
    Neurogenetics, 2005, 6 : 171 - 177
  • [36] LRRK2 as a therapeutic target in Parkinson's disease
    Tan, E. K.
    Schapira, A. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (04) : 545 - 546
  • [37] LRRK2 in Parkinson's disease: biochemical functions
    Anand, Vasanti S.
    Braithwaite, Steven P.
    FEBS JOURNAL, 2009, 276 (22) : 6428 - 6435
  • [38] The Cell Biology of LRRK2 in Parkinson's Disease
    Usmani, Ahsan
    Shavarebi, Farbod
    Hiniker, Annie
    MOLECULAR AND CELLULAR BIOLOGY, 2021, 41 (05)
  • [39] The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research
    Langston, Rebekah G.
    Rudenko, Iakov N.
    Cookson, Mark R.
    BIOCHEMICAL JOURNAL, 2016, 473 : 221 - 232
  • [40] Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson's disease
    Gonzalez-Hunt, C. P.
    Thacker, E. A.
    Toste, C. M.
    Boularand, S.
    Deprets, S.
    Dubois, L.
    Sanders, L. H.
    SCIENTIFIC REPORTS, 2020, 10 (01)